FDA Approves First Drug to Delay Onset of Type 1 Diabetes :

FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).

Related Keywords

United States , Americans , Kevan Herold , Aaron Kowalski , Tracy Olsten , Teplizumab Tzield , Cory Wirt , John Sharretts , Drug Administration On , Diabetes Research Foundation , Claire , Yale School Of Medicine , Career Development Award To Dr , University Of Chicago , Healthday News , Drug Administration , Drug Evaluation , Juvenile Diabetes Research Foundation , Career Development Award , Yale School , New Haven , Consumer News , Type 1 Diabetes , Treatment , Medicine , Harmacology , Natomy , Food And Drug Administration , Drf , H1d , Patient , Drug ,